Colorado Cancer Blogs
  • Home
  • Topics
    • Latest News
    • Research
    • Patient Care
    • Philanthropy
    • C3 Magazine
    • Honors
  • Cancer Types
    • bladder cancer
    • blood cancer
    • brain cancer
    • breast cancer
    • colorectal cancer
    • gynecologic cancer
    • head & neck cancer
    • lung cancer
    • pancreatic cancer
    • pediatric cancer
    • prostate cancer
    • sarcoma
    • skin cancer
Select Page
Less chemotherapy may have more benefit in rectal cancer

Less chemotherapy may have more benefit in rectal cancer

by Garth Sundem | Jan 30, 2020 | Featured, Research

Ashley Glode, PharmD Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx used in this setting come...
Irinotecan breaks cancer cell DNA – AZD0156 keeps the body from repairing it

Irinotecan breaks cancer cell DNA – AZD0156 keeps the body from repairing it

by Garth Sundem | Apr 3, 2019 | Featured, Latest News, Research

The chemotherapy drug irinotecan creates DNA damage leading to cell death and is used to treat colorectal cancer, among other cancer types. Now a University of Colorado Cancer Center study presented at the American Association for Cancer Research (AACR) Annual Meeting...
The Rise of Early Onset Colorectal Cancer

The Rise of Early Onset Colorectal Cancer

by Taylor Abarca | Mar 29, 2019 | Featured, Latest News, Research

More and more young people are being diagnosed with colorectal cancer. The increase is not small—the number of cases is up approximately 40 percent in the last 25 years. This is a stark contrast to the decrease of 40 percent in populations typically affected by...
Colorectal cancer is not an “old person” disease

Colorectal cancer is not an “old person” disease

by Taylor Abarca | Mar 22, 2019 | Featured, Patient Care

Diagnosed with stage 3 colorectal cancer at just 38 years old, Jimmy Zannon was a far cry from the “typical” patient.  Colorectal cancer was once (and often is still) considered a disease of the elderly. With the average age of diagnosis being 68 in men and 72 in...
Colorectal Cancer: What We Know

Colorectal Cancer: What We Know

by Taylor Abarca | Mar 14, 2019 | Featured, Latest News, Patient Care, Research

Colorectal cancer is unique in that, unlike many other cancers, we know how it progresses from healthy to cancerous. We also know how to prevent it and catch it in its early stages, making it one of the only truly preventable cancers. Unfortunately, even with this...
« Older Entries

Colorado Cancer Blogs

  • About Us
  • Comment Policy
  • Cover My News!

CU Cancer Center

  • Find a Doctor
  • Clinical Trials
  • Remote Second Opinion
  • Events

Subscribe to CU Cancer Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

  • Facebook
  • Twitter
  • Instagram

Copyright © 2021 Colorado Cancer Blogs